A new trading day began on Friday, with Novartis AG ADR (NYSE: NVS) stock price up 0.58% from the previous day of trading, before settling in for the closing price of $116.51. NVS’s price has ranged from $92.19 to $120.92 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 0.78%. Meanwhile, its annual earnings per share averaged 15.80%. With a float of $1.96 billion, this company’s outstanding shares have now reached $2.04 billion.
Let’s determine the extent of company efficiency that accounts for 76057 employees. In terms of profitability, gross margin is 74.1%, operating margin of 24.69%, and the pretax margin is 22.67%.
Novartis AG ADR (NVS) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Drug Manufacturers – General Industry. The insider ownership of Novartis AG ADR is 0.00%, while institutional ownership is 7.06%. The most recent insider transaction that took place on Aug 12 ’24, was worth 733,572.
Novartis AG ADR (NVS) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 15.80% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 8.13% during the next five years compared to 5.63% growth over the previous five years of trading.
Novartis AG ADR (NYSE: NVS) Trading Performance Indicators
Here are Novartis AG ADR’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 0.72. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.82. Likewise, its price to free cash flow for the trailing twelve months is 16.31.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 7.85, a number that is poised to hit 1.94 in the next quarter and is forecasted to reach 8.19 in one year’s time.
Technical Analysis of Novartis AG ADR (NVS)
Looking closely at Novartis AG ADR (NYSE: NVS), its last 5-days average volume was 0.76 million, which is a drop from its year-to-date volume of 1.34 million. As of the previous 9 days, the stock’s Stochastic %D was 91.54%. Additionally, its Average True Range was 1.07.
During the past 100 days, Novartis AG ADR’s (NVS) raw stochastic average was set at 83.01%, which indicates a significant decrease from 96.05% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 9.86% in the past 14 days, which was lower than the 15.40% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $116.13, while its 200-day Moving Average is $106.24. However, in the short run, Novartis AG ADR’s stock first resistance to watch stands at $117.60. Second resistance stands at $118.01. The third major resistance level sits at $118.67. If the price goes on to break the first support level at $116.53, it is likely to go to the next support level at $115.87. Should the price break the second support level, the third support level stands at $115.46.
Novartis AG ADR (NYSE: NVS) Key Stats
With a market capitalization of 229.26 billion, the company has a total of 2,044,000K Shares Outstanding. Currently, annual sales are 46,660 M while annual income is 14,850 M. The company’s previous quarter sales were 12,872 M while its latest quarter income was 3,246 M.
